According to Ocuphire Pharma's latest financial reports the company's current revenue (TTM ) is S$22.02 Million. In 2023 the company made a revenue of S$25.15 Million a decrease over the revenue in the year 2022 that were of S$53.42 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.